Explore All Access
Check if your research matches the topics covered in The Lancet Oncology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
The Lancet Oncology : Impact Factor & More
eISSN: 1474-5488pISSN: 1470-2045
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
The Lancet Oncology Key Metrics
CiteScore 
56.9
Eigenfactor
0.1 - 0.5
H-Index
382
Impact Factor
>= 25
Scite Index
0.86 5-Year SI
SJR
Q1Oncology
SNIP
11.42
Topics Covered on The Lancet Oncology
Cancer
Lung cancer
Adjuvant
Chemotherapy
Breast cancer
Medical imaging
Drug discovery
Pembrolizumab
Melanoma
Chemoradiotherapy
Overall survival
Colorectal cancer
Dexamethasone
Quality of life
Toxicity
Placebo
Diffuse large B-cell lymphoma
Observational study
Genetic variation
Methotrexate
The Lancet Oncology Journal Specifications
| Overview | |
| Publisher | ELSEVIER SCIENCE INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in The Lancet Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in The Lancet Oncology
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
- 1 Mar 2024
- The Lancet Oncology
Shortages of essential cancer medicines: who is responsible and what are the possible solutions?
- 1 Jan 2024
- The Lancet Oncology
Universal testing of cutaneous sebaceous carcinoma: a missed opportunity in Lynch syndrome detection
- 1 Jan 2024
- The Lancet Oncology
Morphine manifesto seeks to boost access to oral morphine
- 14 Dec 2023
- The Lancet Oncology
Utilising cancer registry data to monitor cancer burden
- 11 Dec 2023
- The Lancet Oncology
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups
- 31 Oct 2023
- The Lancet Oncology
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
- 1 Mar 2024
- The Lancet Oncology
Shortages of essential cancer medicines: who is responsible and what are the possible solutions?
- 1 Jan 2024
- The Lancet Oncology
Universal testing of cutaneous sebaceous carcinoma: a missed opportunity in Lynch syndrome detection
- 1 Jan 2024
- The Lancet Oncology
Morphine manifesto seeks to boost access to oral morphine
- 14 Dec 2023
- The Lancet Oncology
Utilising cancer registry data to monitor cancer burden
- 11 Dec 2023
- The Lancet Oncology
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups
- 31 Oct 2023
- The Lancet Oncology
Compare Similar Journals with The Lancet Oncology
Select Journals to Compare with The Lancet Oncology
Total journals - 8
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Annals of Oncology
Publisher: ELSEVIER
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
European Journal of Cancer
Publisher: ELSEVIER SCI LTD
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancers
Publisher: MDPI
BMC Cancer
Publisher: BMC
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
0 Journals Selected to compare with
The Lancet Oncology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on The Lancet Oncology
How long has The Lancet Oncology been actively publishing? 
The Lancet Oncology has been in operation since 2000 till date.
What is the publishing frequency of The Lancet Oncology?
The Lancet Oncology published with a Monthly frequency.
How many articles did The Lancet Oncology publish last year?
In 2023, The Lancet Oncology publsihed 102 articles.
What is the eISSN & pISSN for The Lancet Oncology?
For The Lancet Oncology, eISSN is 1474-5488 and pISSN is 1470-2045.
What is Citescore for The Lancet Oncology?
Citescore for The Lancet Oncology is 56.9.
What is the H Index for The Lancet Oncology ?
H Index for The Lancet Oncology is 382.
What is SNIP score for The Lancet Oncology?
SNIP score for The Lancet Oncology is 11.42.
What is the SJR for The Lancet Oncology?
SJR for The Lancet Oncology is Q1.
Who is the publisher of The Lancet Oncology?
ELSEVIER SCIENCE INC is the publisher of The Lancet Oncology.
